Syncromune, a biotech startup working on combination immunotherapies, has put together a $100 million Series A, the company told Endpoints News.
The round was led …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Have you ever seen an award-winning journalist
MSA is a Parkinsonian disease that causes damage to nerve cells. Image credit: Shutterstock/Andrii Vodolazhskyi. The US Food and Drug Administration (FDA) has granted Inhibikase
The clinical trial landscape is changing. What do organisers need to know to navigate potential disruption? Source: Shutterstock. As smaller, leaner organisations that must utilise